Evidence – Advancing the 3Rs Through Integrated Use of 3D Spheroids & In Vivo Models in Immuno-Oncology Development

1:00 pm - Wednesday 2nd December 2026

  • Evaluating how 3D spheroids and advanced in vitro systems can complement in vivo studies to improve biological relevance and reduce animal use
  • Determining which questions require complex in vivo models versus alternative approaches across different stages of development
  • Building robust preclinical evidence packages that balance translational confidence, operational feasibility, and 3Rs principles

Speakers:

Head, Preclinical Pharmacology Medical & Health
Molecular Partners